BioCryst Pharmaceuticals Inc reports results for the quarter ended in January - Earnings Summary

BioCryst Pharmaceuticals

06/05/2024 14:31

* BioCryst Pharmaceuticals Inc  BCRX.OQ  reported a
quarterly
adjusted loss of 17 cents​​ per share for the quarter ended in
January, higher than the same quarter last year, when the
company reported EPS of -28 cents.  The mean expectation of
eleven analysts for the quarter was for a loss of 21 cents per
share. Wall Street expected results to range from -28 cents
to -14 cents per share.
    * Revenue rose 34.9% to $92.76 million from a year ago;
analysts
expected $85.60 million. 
    * BioCryst Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 17 cents​.
    * The company reported a quarterly loss of $35.38 million.
    * BioCryst Pharmaceuticals Inc shares had fallen by 12.4%
this
quarter and lost 25.7% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 4.1%
in the last three months.​ 
    * In the last 30 days, two analysts negatively revised
earnings
estimates

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 10 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"

Wall Street's median 12-month price target for BioCryst
Pharmaceuticals Inc is $11.00 
This summary was machine generated from LSEG data May 6 at 01:30
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.21          -0.17          Beat
 Dec. 31 2023      -0.24          -0.28          Missed
 Sep. 30 2023      -0.23          -0.19          Beat
 Jun. 30 2023      -0.23          -0.24          Missed